Trial · NCT02025998
Development of Ibudilast for Alcohol Use Disorder
NCT02025998, Phase 1, Completed, University of California, Los Angeles
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Development of Ibudilast for Alcohol Use Disorder. Trials, record NCT02025998. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02025998
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Development of Ibudilast for Alcohol Use Disorder
- NCT number
- NCT02025998
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 24 participants, actual
- Lead sponsor
- University of California, Los Angeles
- Conditions
- Alcohol Use Disorders
- Interventions
- Ibudilast, Matched placebo
- First posted
- 2014-01-01
- Last updated
- 2016-02-23
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Subjective response to alcohol | During the alcohol administration and observation period which is expected to last a total of 4 hours | Biphasic Alcohol Effects Scale (BAES) Alcohol Urge Questionnaire (AUQ) |
| Secondary | Stress-Induced Craving | During the stress exposure and observation period which is expected to last a total of 2 hours | Alcohol Urge Questionnaire (AUQ) \& Differential Emotion Scale (DES) |
| Secondary | Cue-Induced Alcohol Craving | During the cue-exposure and observation period which is expected to last a total of 2 hours | Alcohol Urge Questionnaire (AUQ) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R21AA022214 | Development of Ibudilast as a Novel Treatment for Alcoholism | RAY, LARA A. | UNIVERSITY OF CALIFORNIA LOS ANGELES | NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM | 2013 to 2014 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02025998
GET https://conductscience.org/api/trials/v1/NCT02025998/registered